Dexcom’s over-the-counter glucose monitor now offers users an AI summary of how sleep, food and sugar levels are affected.

Dex work made an announcement on Tuesday Artificial intelligence characteristic for it Stelo continuous A glucose monitor that gives users a personalized overview of how food, sleep and activity affect their glucose levels. This is the first iteration of a new creative AI platform the company is building with. Google Cloud.

Stello is one. Over the counter A CGM that measures actual blood sugar levels through the skin. The sensor was launched in August and can be used by any adult who does not take insulin.

The report reflects Dexcom’s effort to make Stelo more personalized and attractive to consumers as it works to enter a new market.

“The No. 1 feedback we get is consumers want to see more,” Dexcom Chief Operating Officer Jack Leach told CNBC in an interview. “They’re making an investment and wearing a product, and they want to be able to make the most of all the data they’re generating.”

Dexcom is using Google. Gemini models And his Vertex AI Platform as the basis of its new AI offering. Vertex AI allows developers to create applications that synthesize different types of data, which can be Notoriously challenging in health care.

Leach said Dexcom is also exploring how its innovative AI platform can be used in its other CGM products, but the company is proceeding with extra caution as patients avoid medical emergencies. So we depend on them.

“It really felt like Stilo was the right place to do it for the first time,” he said.

An existing Insights report is already available to users within the Stelo app, but it follows a more standard weekly template format. Leach said Dexcom believes the AI-generated report will be more valuable to consumers because it’s more personalized.

If there’s a week where the user isn’t moving enough after eating, for example, the report will include relevant tips and educational content to help.

Leach said Stelo’s AI reports do not provide medical advice to consumers, although Dexcom is using the US Food and Drug Administration’s AI framework to guide the development of the feature. FDA Approved Stelo in March.

Finally, Dexcom wants to use its creative AI platform to provide customers with real-time feedback rather than just weekly reports. The company is also exploring how the technology can serve as a predictive indicator for potential problems, similar to the check engine light on a vehicle.

“It gives you an idea of ​​what’s going on, and recommendations on where you might want to go for more advice,” Chris Sakalowski, Google Cloud’s vice president of strategic industries, told CNBC in an interview.

Dexcom’s updated weekly report began rolling out to Stelo users this week.